Evaluation of liposomal formulation of placenta extract after microneedling in the treatment of skin aging

Evaluation of the safety and effectiveness of liposomal formulation of placenta extract after microneedling in the treatment of skin aging

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200127046282N23

Enrollment

Registered

2023-02-05

Start date

2023-02-20

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin aging. Atrophic disorder of skin

Interventions

Intervention 1: Control group: the patient receives the non-liposomal product immediately after microneedling in three sessions with an interval of one month. Intervention 2: Intervention group: the p

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 20-60 Having middle wrinkles in face region

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding History of cancer Patients with a new history of gel and Botox injections People with Mental Disorders Active infection in the face

Design outcomes

Primary

Measure	Time frame
The amount of wrinkles. Timepoint: Before treatment and six month after the last session. Method of measurement: Visio face.	—

Secondary

Measure	Time frame
Inflammation. Timepoint: After each session. Method of measurement: Questionnaire and visit.;Intensity of pain. Timepoint: Treatment time. Method of measurement: Questionnaire and visit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and stem Cell Research Center, Tehran University of Medical Sciences

sonazarebio@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026